Pluristem Therapeutics - The Hidden Niche Player
Seeking Alpha,
Summary Stem cell companies are approaching market commercialization. Pluristem is an interesting candidate.
Summary Stem cell companies are approaching market commercialization. Pluristem is an interesting candidate.
Summary Zimmer Biomet is one of the leading medtech companies in the promising medtech arena.
Hip fractures in elderly patients represent a health issue of global proportions.